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Autism
Producing neurons, 
tracking behaviors  
to fight the disorder  
Pathways to
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COVER   Populations of neurons 
derived from the cells of patients and 
their families may provide clues to 
autism’s genetic roots. Story on page 10. 
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 10  Unraveling autism  
Researchers are using three major approaches to under-
stand the disorder’s physical and psychological basis. 
17    Sparking curiosity 
For 25 years, the Young Scientist Program has increased 
participation of underrepresented groups and brought 
resources directly to K-12 schools. 
22    Resisting Zika 
Working quickly and collaboratively, School of Medicine 
scientists are on the leading edge of this growing public 
health crisis.
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Not a spectator sport: The Young 
Scientist Program brings hands- 
on fun and serious insights to K-12 
students. Story on page 17.
In a healthy mouse, sperm (represented in pink) 
are abundant and flourishing. A recent study in 
mice revealed that the Zika virus breaks down 
the internal structure of the testes and lowers 
fertility. The finding could have implications for 
men. See story, page 22. 
Shondra Miller, PhD (standing), and 
her team in the Genome Engineering 
and iPSC Center isolate epithelial cells 
in urine samples and convert them 
to stem cells. Another lab coaxes 
the stem cells into neurons. These 
scientists are playing a critical role 
in autism research at the School of 
Medicine. See story, page 10. 
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W ith a goal of treating worn, arthritic hips without joint-replacement surgery, 
scientists have programmed stem cells  
to grow new cartilage on a 3-D template 
shaped like the ball of a hip joint. What’s 
more, using gene therapy, they have 
activated the new cartilage to release  
anti-inflammatory molecules to fend off  
a return of arthritis.
The technique, a collaborative effort 
between the School of Medicine and  
Cytex Therapeutics Inc. in Durham, North 
Carolina, is described in Proceedings of  
the National Academy of Sciences.
The scientists have tested various 
aspects of the tissue engineering in cell 
culture, and customized implants already 
are being tested in laboratory animals. Such 
devices could be ready for safety testing in 
humans in three to five years. 
The discovery one day may provide an 
alternative to hip-replacement surgery, 
particularly in younger patients. Doctors 
are reluctant to perform such operations in 
patients under age 50 because prosthetic 
joints typically wear out after about 20 
years. A second joint-replacement surgery 
to remove a worn prosthetic can destroy 
bone and put patients at risk for infection.
“Our hope is to prevent, or at least 
delay, a standard metal and plastic 
prosthetic joint replacement,” said Farshid 
Guilak, PhD, professor of orthopedic 
surgery, of developmental biology and of 
biomedical engineering. Guilak also is the 
director of research at Shriners Hospitals for 
Children-St. Louis and co-director of the 
Washington University Center of 
Regenerative Medicine.
The technique uses a biodegradable, 
synthetic scaffold that Guilak and his team 
developed. The scaffold, molded into the 
precise shape of a hip joint, is covered with 
cartilage taken from a patient’s stem cells. 
The stem cells are converted from fat cells 
and reprogrammed into cartilage. The 
scaffold then can be implanted. 
Resurfacing the hip joint with living  
tissue is designed to ease arthritis pain.
By inserting a gene into the newly 
grown cartilage and activating it with  
a drug, the implant also can orchestrate  
the release of anti-inflammatory molecules 
to fight a return of arthritis, which often 
triggers joint problems. 
See weaving technique, back cover.
pulse
Biomedical engineering PhD 
student Ali Ross and Farshid 
Guilak, PhD, show a container 
with a prototype of a living  
hip replacement. 
A 3-D, biodegradable, synthetic scaffold has been 
molded into the precise shape of a hip joint. 
Stem cells engineered to grow cartilage
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ALAN L. SCHWARTZ, PHD, MD,  the Harriet B. 
Spoehrer Professor, who until earlier this year had served  
as head of the Department of Pediatrics for 21 years, was 
celebrated at a symposium. Schwartz will devote more time  
to national leadership commitments, mentoring faculty and 
trainees, and to his research.
Stem cells engineered to grow cartilage
MD/PhD student Jonathan B. Lin (left) and  
Rajendra S. Apte, MD, PhD
A woman in India suffers severe swelling 
in her legs due to elephantiasis.
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e Bill & Melinda Gates Foundation has awarded the 
School of Medicine a two-year, $8 million grant to evaluate 
an investigational treatment for a neglected tropical disease.
More than 1 billion people in 73 countries live at risk of 
lymphatic filariasis. Without effective treatment, the infec-
tion can lead to massive swelling and deformity of the legs, 
known as elephantiasis.
e grant supports a  
team led by Gary J. Weil, 
MD, professor of medicine 
and of molecular microbiol-
ogy. Weil has studied lym-
phatic filariasis — which is 
caused by parasitic worms 
and spread by mosquitoes 
— for decades. His earlier 
research led to a new diag-
nostic test for the disease. 
e grant will fund multicenter studies of an investigational 
triple-drug treatment – ivermectin, diethylcarbamazine and 
albendazole, also known as IDA. e community-based 
studies will enroll more than 30,000 people.
Recent clinical trials have shown that the three-drug 
regimen is more effective than the currently used two- 
drug regimens of diethycarbamazine plus albendazole, or 
ivermectin plus albendazole. In addition, it may only need 
to be given once while the two-drug treatment needs to be 
repeated for many years.
 “If our studies confirm the safety and effectiveness of 
the triple-drug regimen, the treatment could be a game 
changer in accelerating the global program to eliminate 
lymphatic filariasis in the developing world,” Weil said.
$8 million grant supports drug studies 
to eliminate lymphatic filariasis
e eye’s retina works like film in a camera. e retina’s  
rods sense dim light, while cone cells detect colors, contrasts 
and sharp images seen during daylight. A wide range of 
disorders can damage those rods and cones and lead to 
vision loss. School of Medicine researchers have identified  
a pathway involved in harming rods and cones and have 
found a way to halt that damage.
Targeting the pathway with therapies could preserve sight in 
patients with many types of retinal disorders, including those 
for which there are no treatments, such as retinitis pigmentosa 
and advanced dry age-related macular degeneration.
e findings 
are published in 
the journal Cell 
Reports.
“We believe we 
have uncovered a 
unifying pathway 
involved in 
inflicting severe 
damage to and even 
causing the death 
of rods and cones,” 
said Jonathan B. Lin, 
an MD/PhD student 
and co-first author 
with Shunsuke Kubota, MD, PhD, a former postdoctoral 
fellow. “ese findings should help us develop treatments  
for retinal disorders, regardless of what’s causing them.”
Lin works in the lab of senior investigator Rajendra S. 
Apte, MD, PhD, the Paul A. Cibis Distinguished Professor 
of Ophthalmology and Visual Sciences. In a series of 
experiments first in mice and later in retinal cells, they 
identified a key molecule — NAD (nicotinamide adenine 
dinucleotide) — in the cascade that leads to the death of  
the retina’s rods and cones.
Photoreceptor cells such as rods and cones are among the 
biggest energy users in the body. e researchers identified 
problems in the cells’ mitochondria — where energy is 
produced — as a culprit in vision loss. e NAD molecule  
is known for its important role in energy production. 
When the researchers treated damaged photoreceptor 
cells in mice with NMN (nicotinamide mononucleotide) 
— a precursor molecule that boosts NAD levels— the cells’ 
degeneration ceased and vision was restored. NMN is of 
particular interest to scientists who study problems related 
to aging.
Apte expects human clinical trials could begin soon. 
Culprit identified as major 
cause of vision loss
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When Adriana Isaac graduated from McCluer High School 
in Florissant, she didn’t know what she wanted to do with 
her life. Although she had worked at Pizza Hut through 
high school and was promoted to manager aer graduation, 
remaining in that job would mean working nights and 
earning less than $10 an hour.
“I knew the pay wasn’t going 
to provide for my family, and 
the hours weren’t working well 
with raising children,” she said.
In July, Isaac began working  
as a medical assistant aer 
participating in a new 
internship program. e 
program was created for  
adults with an interest in  
health sciences through a 
partnership involving the 
School of Medicine, the 
University of Missouri- 
St. Louis and St. Louis 
Community College.
Medical assistants — normally trained through area trade 
schools — bring patients into exam rooms, assess vital signs 
and document the primary reasons for their visits to doctors’ 
offices and clinics.
e positions are difficult to fill and recently have become 
more so because students now have to pass a national 
certification exam. Training program enrollment also is low 
because students find it challenging to attend school for an 
average of 20 weeks without income. e internship provides 
students with an income during training. Interns are asked to 
make a two-year employee commitment aer completion.
“is program was a life-changer for me and my family,” 
said Isaac, who now works as a registered medical assistant in 
pediatric surgery for the medical school. 
e idea grew out of the university’s interest in supporting 
recommendations outlined by the Ferguson Commission. 
Missouri Gov. Jay Nixon appointed the 16-member board 
in November 2014 in the wake of unrest following the death 
of Michael Brown. e commission issued a report titled 
“Forward rough Ferguson: A Path Toward Racial Equity.”
Higher education leaders zeroed in on a need for more 
economic mobility for residents of north St. Louis County 
and north St. Louis. Leaders on the Medical and Danforth 
campuses reached out to partner institutions, helped establish 
the curriculum, recruited the first class of trainees and placed 
them in clinical departments. Participating departments include 
medicine, orthopedics, surgery, neurology and neurosurgery. 
Response to Ferguson
Medical internship provides opportunities
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Man’s paralyzed hand moves again
In 2015, quadriplegic 
Tim Raglin became the 
first person in Canada 
to undergo a nerve 
transfer surgery to 
restore some 
movement to his 
hand. Raglin had been 
unable to move his 
hands or legs since 
shattering a vertebra 
in a diving accident 
nine years earlier. 
School of Medicine 
surgeons Susan E. Mackinnon, MD, who pioneered the 
technique, and Ida K. Fox, MD, traveled to Canada to 
supervise as Kirsty Usher Boyd, MD, formerly a surgical 
fellow at Washington University, performed the delicate 
operation. The surgeons took a still-functioning nerve 
that controlled Raglin’s elbow and sutured it onto a 
pathway toward his right hand. For a year after surgery, 
Raglin felt nothing at all; damaged nerves regrow very 
slowly. Then, in February 2016, his index finger twitched. 
Now he can unfold his fingers and grip implements such 
as a fork, shaver and toothbrush. The process has been 
exhilarating for Boyd and Raglin. “It’s all about 
independence,” Raglin said.
UPDATE TO SUMMER 2016 OUTLOOK STORY
Adriana Isaac
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upplementing healthy mice with 
a natural compound called NMN 
can compensate for loss of cellular 
energy production, reducing typical signs of 
aging. The study is published in the journal 
Cell Metabolism.
“We have shown a way to slow the 
physiologic decline that we see in aging 
mice,” said Shin-ichiro Imai, MD, PhD, 
professor of developmental biology and 
of medicine. “This means older mice have 
metabolism and energy levels resembling 
that of younger mice. Since human cells rely 
on this same energy production process, we 
are hopeful this will translate into a method 
to help people remain healthier as they age.”
Imai is working with researchers 
conducting a clinical trial to test the safety 
of NMN in healthy people. The phase 1 trial 
began earlier this year at Keio University 
School of Medicine in Tokyo.
With age, the body loses its capacity to 
make a key element of energy production 
called NAD (nicotinamide adenine 
dinucleotide). Past work by Imai and 
co-senior author Jun Yoshino, MD, PhD, an 
assistant professor of medicine, has shown 
that NAD levels decrease in multiple tissues 
as mice age. Research also has shown that 
NAD is not effective when given directly to 
Compound reduces signs of aging in mice
S
mice so the researchers sought an indirect 
method to boost its levels. To do so, they 
only had to look one step earlier in the NAD 
supply chain to a compound called NMN 
(nicotinamide mononucleotide).
NMN can be given safely to mice and 
is found naturally in a number of foods, 
including broccoli, cabbage, cucumber, 
edamame and avocado. 
The new study shows that when NMN is 
dissolved in drinking water and given to mice, 
it appears in the bloodstream in less than 
three minutes. Importantly, the researchers 
also found that NMN in the blood is quickly 
converted to NAD in multiple tissues.
The researchers found a variety of 
beneficial effects, including in skeletal muscle, 
liver function, bone density, eye function, 
insulin sensitivity, immune function, body 
weight and physical activity levels. 
Building  
connections
Move-in has begun at Mid Campus Center (MCC),  
left, a 12-story building at 4590 Children’s Place,  
just north of the Central West End MetroLink Station. 
The MCC further consolidates operations by housing 
collaborative and administrative space for Barnes-
Jewish and St. Louis Children’s hospitals and the 
School of Medicine, including the dean’s office, as 
well as a joint emergency command center. This 
move provides more space for medical school faculty 
and clinics in other locations, such as at the Center 
for Outpatient Health. The MCC features a cafe, 
bookstore and extensions to the elevated walkway 
system, improving campus connectivity. Except for 
shelled space, the MCC will be fully occupied by April.
Older mice drinking water supplemented with  
NMN resembled younger mice in measures of 
metabolism and energy production.
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Obstetrician/gynecologist George  
Macones, MD, has been elected to 
the National Academy of Medicine. 
Membership in the organization is one  
of the highest honors in the fields of  
health and medicine in the U.S.
Macones is the Mitchell and Elaine 
Yanow Professor and chair of the 
Department of Obstetrics and Gynecology.
He is among 70 regular members 
and 9 international members whose election to the National 
Academy of Medicine was announced in October. Current 
members of the organization elect new members based on  
their contributions advancing public health, health care and 
medical science. All members volunteer time to serve on  
committees examining a broad range of health policy issues.
Macones, also chief of obstetrics and gynecology at  
Barnes-Jewish Hospital, is a specialist in maternal-fetal  
medicine. He has expertise in caring for pregnant women with 
complicated pregnancies and those at risk for preterm birth.
e author or co-author of more than 300 scientific articles, 
he is internationally renowned for his research on the safety of 
vaginal birth aer cesarean sections and developing new guide-
lines on monitoring fetuses during labor. He directs the March of 
Dimes Prematurity Research Center at Washington University.
Macones elected to National Academy
Some 10 million points of genetic variation are scattered 
across a molecule of DNA, and those variations make us 
who we are as individuals. But in some cases, those variants 
contribute to diseases, and it’s a major challenge for scientists 
to distinguish between harmless variants and those that are 
potentially hazardous.
Now, School of Medicine researchers have developed 
a technique to cheaply and rapidly create myriad sets of 
DNA fragments that detail all possible genetic variants in a 
particular stretch of DNA. By studying such DNA fragments, 
scientists can more easily distinguish between genetic 
variants linked to disease and those that are innocuous.
e findings, published in Nature Methods, allow 
researchers to create sets of DNA variants in a single day 
for a few hundred dollars. Current methods take up to a 
week and cost tens of 
thousands of dollars.
“As a pediatric 
neurologist who does a 
lot of genetic studies of 
kids with developmental 
disabilities, I frequently 
will scan a patient’s 
whole genome for genetic 
variants,” said Christina 
Gurnett, MD, PhD, the 
study’s senior author and 
an associate professor 
of neurology and of 
pediatrics. “Sometimes 
I’ll find a known variant that causes a particular disease,  
but more oen than not I find genetic variants that no one’s 
ever seen before, and those results are very hard to interpret.”
Postdoctoral researcher Gabriel Haller, PhD, who was 
working in Gurnett’s lab, realized that he could harness 
common laboratory techniques and tools to create sets of 
DNA variants without the expensive equipment and reagents 
that drove up the price.
Haller copied a DNA sequence using the four standard 
DNA letters and a nonstandard letter known as inosine. 
Each copy of the sequence was identical except for one 
inosine, which was located at a random spot and served as 
a placeholder. en, he replaced the inosine with one of the 
standard DNA letters, creating a single mutation in each 
copy of the sequence.
Gurnett envisions the creation of a catalog listing the 
effects of every possible variant.
Sets of DNA variants: a 
cheaper, faster solution
THE AGING BRAIN  A research team led by Washington 
University scientists will scan the brains of kindergartners 
to centenarians to capture the changes that occur as brains 
develop, mature and age over the lifespan. The endeavor, a  
followup to the Human Connectome Project, is funded by  
two grants totaling $34 million from the National Institutes  
of Health (NIH). The above composite image shows healthy 
adult brains at rest, as captured by MRI. 
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Anew type of immunotherapy shows promise against acute myeloid leukemia (AML) cases 
that recur or never respond to treatment. 
A small clinical trial at the School of 
Medicine provides evidence that the 
immune system’s “natural killer” cells  
can be dialed up in the lab and trained 
to destroy cancer cells in some patients. 
The findings are published in Science 
Translational Medicine.
In the trial of nine patients, four 
achieved complete remission; there  
was no evidence of leukemia for at least 
one month after treatment. One patient 
achieved a partial remission, with some 
abnormal cells reappearing at the one-
month mark. The remaining four patients 
did not respond to the therapy. 
The longest complete remission  
lasted about six months. The average  
life expectancy for patients with active  
AML that does not respond to therapy is 
about three months.
“This is a small study, but a 50 percent  
response rate is promising since these 
are patients with very 
poor prognoses and very 
few options,” said Todd A. 
Fehniger, MD, PhD, co-principal 
investigator of the study and an 
associate professor of medicine. 
Natural killer (NK) cells are 
immune cells that can attack 
tumor cells and cells infected 
by viruses. For this therapy, 
the NK cells are taken from a 
closely related donor, separated 
from the rest of the blood, 
and incubated overnight in a mixture of 
interleukins 12, 15 and 18. These chemical 
signals activate and train the NK cells to 
attack leukemia cells more effectively in  
the patient following infusion.
Rizwan Romee, MD, co-principal 
investigator of the study and an assistant 
professor of medicine, refers to the process 
as “boot camp.”  “When the NK cells see the 
real cancer for the first time, they remember 
their training and respond more effectively 
than cells that don’t have this exposure.” 
This phase 1 trial primarily was  
designed to test the safety of the new 
therapy. “We saw remissions at each dose 
level, even the lowest one,” Fehniger said. 
“Now that we have established the safety 
of this immune therapy, we would like 
to find out how consistently the patients 
respond when we treat a large number at 
the highest dose level, which is what we’re 
in the process of doing now.” 
Immunotherapy for leukemia shows promise
Samuel Achilefu, PhD, the Michel M. Ter-
Pogossian Professor of Radiology, is the 
first recipient of the Breast Cancer Research 
Program Distinguished Investigator Award 
from the U.S. Department of Defense.
The $4.5 million award will support  
his efforts to develop a safer, more 
effective way to treat breast cancer than 
currently available chemotherapy drugs. 
Using a mouse model of cancer, 
scientists led by Achilefu devised a way 
to apply light-based therapy, known as 
phototherapy, to deep tissues never  
before accessible with this method. They 
delivered light directly to tumor cells via  
an imaging agent frequently used in 
positron emission tomography (PET)  
scans. This light source, along with  
a novel cancer-targeting product and  
a chemotherapy drug, selectively kills 
cancer cells.
Long used in cancer treatment, 
phototherapy is effective only as far as  
light can penetrate. This has limited  
usage to skin cancers and areas of the 
body accessible with an endoscope.
Co-investigators are Katherine N. 
Weilbaecher, MD, professor of medicine, 
and Robert D. Schreiber, PhD, the Alumni 
Endowed Professor of Pathology and 
Immunology.
Innovative light therapy able to reach deep tissues
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Viewed through a microscope, NK cells 
incubate in a chemical cocktail.
Sets of DNA variants: a 
cheaper, faster solution
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L ife on the brink of death  inspired the poetry of two  School of Medicine students  
who won first and second place in an 
annual competition sponsored by the Alpha 
Omega Alpha Honor Medical Society (AOA).
Michael Slade’s first-
place poem, “Requiem,” 
and Alexandra Houston-
Ludlam’s second-place 
piece, “My First Patient,” 
were published in AOA’s 
literary journal The Pharos.
“Winning the top two 
spots is unprecedented,” 
said Morton E. Smith, MD, 
professor emeritus of 
ophthalmology and visual 
sciences, associate dean 
emeritus and councilor for 
the school’s Alpha Omega Alpha chapter.  
“It speaks to the compassion and talent of 
Michael and Alexandra.”
Altogether, AOA received 123 poetry 
submissions from chapters across the country.
“For two students from the same 
institution to rise to the top is an 
extraordinary feat,” said Dee Martinez, 
managing editor of The Pharos.
Slade, a fourth-year medical student, 
said the patient he wrote about came from 
a blend of experiences and conversations 
he has had with attending physicians, 
residents and other medical students.  
“He’s a product of frustrations I’ve had  
with friends and relatives,” Slade said.  
“He is also, more than a little bit, me.
“When you start working in the hospital 
in your third year of medical school, 
absolutely everything is overwhelming,” 
Slade continued. “You’re trying to keep 
track of a million tasks and impress a 
seemingly endless parade of people 
evaluating you. It’s easy to lose track of  
the fact that, as future physicians, we’re a 
part of seminal events in people’s lives. 
“Writing is a chance to stop and reflect, 
to synthesize the stress and the chaos and 
the heartbreak we see and participate in  
on a daily basis. It’s a chance to find 
something meaningful in what often  
feels completely random.”
Inspired by first-semester anatomy  
lab, Houston-Ludlam wrote about her 
expectations compared with her realities  
of medical school. “Before I came here,  
I saw the science of medicine being distinct 
from the interpersonal intimacy of 
physician-patient contact,” she said.
“The people who donate their bodies  
to Wash U for the purpose of furthering 
medical education have had a significant 
impact on me,” said Houston-Ludlam,  
who is enrolled in the Medical Scientist 
Training Program. 
“In my case, this person not only taught 
me about human anatomy, using the 
physical self as an example. This person  
also helped me practice how to put aside 
my own reservations and anxieties to focus 
on the patient-centered task at hand, and 
serves as a metaphor for my transition to 
medical student. This poem is first and 
foremost an expression of my gratitude  
to this person.”
Students win national poetry contest
Alpha Omega Alpha Honor Medical Society publishes their work
From left, Alexandra 
Houston-Ludlam, 
Morton E. Smith, MD, 
and Michael Slade.
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Requiem
I find you outside, smoking
oxygen tank placed carefully to the side
basking in the last colors of the fall
I would’ve covered you in nicotine patches
gone back in time and snuffed your cigarette
when you first stole one from Dad’s pack
and lit it out behind the shed
trying to hide the scent with Febreze
and orange-scented hand sanitizer
With each drag, your cells shivered
swelling until some poor intern
sat down on the edge of your bed
and stuttered out a death sentence
“We’ve found something”
as if it could be treasure or puppies
and isn’t always something ugly and slimy
slithering forth from an organ system
you’d long stopped considering
I sit down on the bench beside you
and watch the ambulances go by
You smile crooked and ask if I want one
I laugh, knowing my wife will kill me
just for having the smoke on my jacket
and that bitter look in the back of my eyes
A moment of silence slides past us
joining the bustling exodus
of newly christened and sacred old
Finally, you turn and ask me how long
I’m sure your world will never be green again
but will end in brown or red or gold
Instead I tell you it’s hard to know
and you pull deeply on your cigarette
Each of us charts our course
and waits for the last leaf to fall.
Michael Slade
My first 
patient
I always pictured my first patient to be
wrapped in a dressing gown
frail and thin
laying in a hospital bed
kindly, quietly answering the many questions I would ask
 as a beginning medical student.
My first patient is
wrapped in muslin
cold and swollen
laying on a metal table
 kindly, silently answering the questions I never knew
 I would ask as a beginning medical student.
I always expected my most intimate patient moments  
to be
 dealing with the devastation of personal illness and loss
 described in words and punctuated with tears
like the most intimate moments I’ve shared with family
 and friends.
My most intimate patient moment is
peeling away layers of skin and flesh and bone to discover
 what lies beneath
holding the nerve that controlled the hand that touched
 family and friends with warmth and love
unlike anything I have ever experienced with another
 human being.
I always expected my first patient to teach me
the clinical presentation of some disease process I recently
 learned in class
the human side of disease and illness
how to be a good doctor
with words and stories and mannerisms.
I never expected my first patient to teach me
that a cancerous lymph node looks like a black and white
 marble with the texture of a dried bean
the specific sound of separating fibrous cobwebs of
 collagen encapsulating arm and leg compartments
how to be a good human
without ever speaking a word.
    Alexandra Houston-Ludlam
Students win national poetry contest
Outlook  9
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Like many patients visiting a doctor’s office, Kim 
Sebenoler started out her appointment by heading to 
the nearest restroom to give a urine sample. But her 
visit to the lab of John Constantino, MD, director of the 
William Greenleaf Eliot Division of Child Psychiatry, 
was not a typical exam. e goal was not to measure 
proteins in her urine or check her overall wellness. 
Instead, researchers took her urine cells to replicate 
human brain cell function in a Petri dish. e study 
is one of three major approaches School of Medicine 
researchers are using to unravel the physical and 
psychological underpinnings of autism. e unique, 
multifaceted effort — studying genes, brain activity 
patterns and behavior — is giving researchers and 
practitioners a better understanding of the disorder, 
which today affects one in every 100 Americans.  
e cells are helping co-investigators Constantino 
and neuroscientist Azad Bonni, MD, PhD, explore how 
brain function changes in people with autism spectrum 
disorder (ASD). Both researchers are international 
leaders — Constantino in clinical autism studies and 
Bonni in advancing understanding of the underlying 
mechanisms of brain development.
Unraveling
autism
Outlook  11
Multifaceted approach aims to detect,
treat and even reverse the disorder.
B Y  R E B E C C A  B O Y L E
Kim Sebenoler, center, and her daughter, 
Sarah, along with other family members, are 
helping psychiatrist John Constantino, MD, 
understand the roots of autism. Kim carries, 
but does not express, a rare genetic mutation 
that may play a role in her twin boys’ autism.
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Autism is most commonly characterized by repetitive behaviors and difficulty with communication and social 
interaction. It has a multitude of forms, and 
psychologists recognize a wide spectrum of  
skills, symptoms and disability. 
“We are engaging people across disciplines  
— geneticists, molecular biologists, child 
psychologists, neuropsychologists and human 
brain imaging researchers,” said Bonni, the  
Edison Professor of Neuroscience and chair of  
the Department of Neuroscience. “ere is no 
single pathway toward treatment or discovery.  
It’s absolutely the case that we need multifaceted 
approaches. Washington University is uniquely 
positioned to address these challenges.”
Researchers collected urine samples from 
several members of the Sebenoler family, including 
daughter Sarah, 18, and 16-year-old identical twin 
boys, Mark and Jack. Kim Sebenoler is not on the 
autism spectrum, and Sarah has not been formally 
diagnosed, but the twins were diagnosed at age 3.
e researchers took the samples and separated 
solid material from liquid material. ey isolated 
epithelial cells, a type of cell found in the lining of 
the kidneys that the body sheds all the time. From 
these, they produced induced pluripotent stem 
cells, which can become any type of cell in the 
body. en, they reprogrammed the stem cells 
into neurons. is yielded a population of brain 
cells that could be studied, enabling side-by-side 
comparisions. Researchers are continuing to watch 
for variations in neuron viability and activity. 
Later, the Sebenolers returned to the lab for 
brain imaging studies, so researchers can study 
activity in their entire brains, not just cells in a 
Petri dish. 
e family has participated in studies on 
autism prevalence in twins, and Kim’s son 
Nicholas, 9, is part of a study examining  
the younger siblings of children with autism.  
Nicholas has participated since he was a baby,  
and is helping researchers study the earliest 
possible evidence for autism-related symptoms, 
which may be visible as soon as 2 months of age. 
Ultimately, the researchers are trying to diagnose 
and treat autism as early as possible, aiming to 
develop treatments and possibly drugs that can halt 
or even reverse autism-related symptoms.
“Identifying genetic susceptibilities —  
and how they relate to the development of a  
human brain, and how genetic liabilities early in 
development could take a child off track — those 
are all of very high interest to us,” said Constantino, 
the Blanche F. Ittleson Professor of Psychiatry and 
Pediatrics and psychiatrist-in-chief at St. Louis 
Children’s Hospital.
He and Bonni say with early diagnosis and a 
suite of treatment options, doctors may be able to 
re-route children toward a developmentally typical 
track — rewiring their neurological trajectories, and 
eliminating or preventing autism-like behaviors.
How are neurons 
created?
Researchers isolate epithelial 
cells found in urine. 
The cells are regressed into 
nimble stem cells.
Stem cells are converted  
into neurons.
Researchers observe neuron 
function in Petri dish. 
164485_Autism_CC15.indd  12 12/5/16  1:32 PM
outlook.wustl.edu Outlook  13
The Kroll lab has figured out not only how to create neurons, 
but also to create neuron types that perform specific functions. 
These types — cortical excitatory neurons and inhibitory 
neurons — often are abnormal in patients with autism. This 
process includes a specific chemical treatment to generate 
these types of neurons in a Petri dish. In this case, populations 
of neurons are derived from the cells of the Sebenoler 
family. From left, Kristen Kroll, PhD, associate professor of 
developmental biology, and postdoctoral fellow Kesavan 
Meganathan, PhD.
Rates of autism diagnosis have skyrocketed in 
recent years, but scientists say this is due to 
improved diagnostic techniques, not necessarily 
an increase in people with the disorder. 
Autism is highly heritable; a person with an 
autistic sibling is 20 times more likely than a 
person in the general population to also develop 
autism. Among identical twins, like Mark and  
Jack Sebenoler, if one twin has autism there is a  
95 percent likelihood that the other twin will 
develop autism — evidence that suggests a strong 
genetic link. Most commonly, autism results from 
an accumulation of subtle genetic changes.
Female protective effect
With help from the Sebenolers and funding from 
the National Institutes of Health (NIH), 
Constantino and Bonni are trying to tease out 
genetic markers that might offer a protective effect 
against autism. Earlier, the researchers showed 
that autism is four times more likely to develop in 
boys than girls not because autism favors the male 
sex, but because most girls seem to be relatively 
protected. Capturing this protective effect — the 
effect of the extra X chromosome — could be a way 
to treat or reverse autism symptoms.
“Females carry the same genetic factors, but they 
don’t express them, which is a huge clue. We think 
that’s going on all the time in autism transmission,” 
Constantino said. “If we understood the biology of 
that, we could harness biology to treat the children 
who succumb to the genetic liability.”
In the Sebenolers, the research team has located 
a rare genetic mutation that is likely to have a 
significant role in causing the boys’ autism, and is 
carried (but not expressed) by their mother.
“We wanted to know, is there a way that we 
could identify, at the level of an individual cell, 
whether the neuron of a female carrying a mutation 
is behaving differently than a neuron of a male 
carrying this mutation?” he said. “If the difference 
is traceable to a cell, there is a better chance that 
pharmaceutical targets might be identified.”
In one study published last year, Constantino 
and colleagues at the University of California- 
San Francisco were unable to isolate a single gene 
that conferred protection to females. He is still 
looking, but noted that whatever biological defense 
is protecting females might not be obvious at the 
behavioral level. It might be more obvious at a 
cell- or tissue-based level, which is why the 
researchers have elected to differentiate 
populations of neurons derived from the cells  
of the family members themselves. 
Alternatively, that protective effect might play 
out in a particular pattern of brain activity, which 
researchers can study using functional magnetic 
resonance imaging (fMRI). e Sebenolers, and 
many other patients, are taking part in studies 
that will look at all these factors. 
Bonni said researchers are still trying to 
understand whether people on the spectrum  
share common traits. “It will be easier to develop 
therapies if we identify common mechanisms.  
On the other hand, assuming there are multiple 
different mechanisms, we will have to address 
those, and the approach that we’re taking with this 
family is the way to do it. at’s an example of 
laying the foundations for precision or personalized 
medicine. We have to consider both approaches as 
we move forward.”
Autism is four times more likely 
to develop in boys than girls 
not because autism favors the 
male sex, but because most girls 
seem to be relatively protected. 
Girls carry the same genetic  
factors, but don’t always express 
them. Capturing this protective 
effect could be a way to treat or 
reverse autism symptoms.
Potential clues?
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The developmental disorder, which today affects one in every 100 Americans, manifests in a multitude of forms, with a  
wide spectrum of symptoms and disabilities. Because of this, 
School of Medicine researchers are using three major approaches 
to understand the disorder’s physical and psychological basis. 
Researchers say there is no single pathway toward treatment. 
Advancing three frontiers against
Autism
Brain  
mapping
Do structural differences play a role?
Preliminary evidence suggests there are unique 
features of early brain structure and function among 
patients with autism. By comparing brain scans, 
scientists may be able to find physical evidence of 
autism and use that data pre-symptomatically to 
determine which child will develop the disorder.
Behavior
What do children with autism see?
Young children with autism avoid eye contact, 
and are captivated by inanimate objects. Such 
tendencies are visible at 2 months of age. Eye-
tracking technology may detect these warning  
signs, and early therapeutic intervention could 
prevent autism-like behaviors.
Biology
Can autism be traced to a cellular level?
Because autism involves higher orders of 
thinking, animal models often are insufficient 
to test theories. And brain cells cannot be safely 
removed from patients. By taking human urine 
cells and converting them to neurons, researchers 
can explore genome-regulated function and 
development in a Petri dish. 
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Scientists have spent decades studying gene 
mutations that can lead to problems or disorders. 
Now they are increasingly focusing on genetic  
and environmental factors that might provide 
resilience to disorders, said Bradley Schlaggar, 
MD, PhD, the A. Ernest and Jane G. Stein 
Professor of Developmental Neurology, head of the 
Division of Pediatric Neurology, and neurologist-
in-chief at St. Louis Children’s Hospital.
Schlaggar and Constantino co-direct 
Washington University’s 6-year-old Intellectual  
and Developmental Disabilities Research Center 
(IDDRC). is signature research effort seeks to  
find better prevention and treatment strategies for 
childhood developmental disabilities, including 
autism and the neurodevelopmental consequences 
of preterm birth.
e so-called “resistome” is more difficult to 
study, Schlaggar said, especially in formal clinical 
research, because there are so many competing 
and confounding factors; it’s difficult to control  
for every possible thing that could make someone 
more or less susceptible to autism. 
“e pathway to treat the disease may not come 
from turning off or on the gene that is a problem, 
but recapitulating what the organism is doing to 
provide protection,” he said. “It’s not gratifying, 
though. It’s a strategy that doesn’t really lend itself 
to the usual scientific methods. It requires a big 
data approach. All the fundamental parameters of 
investigation are challenged by this strategy.”
Predicting outcomes
Just as genomics-based medicine is enabling 
personalized treatments, brain imaging is 
increasingly used not only to observe behavior  
and diagnose disorders, but to make predictions 
about a person’s possible outcomes.
Constantino, Schlaggar and their colleagues  
are using functional MRI and functional 
connectivity MRI to study brain architecture  
and understand how the brain’s physical  
attributes can affect a person’s psychological 
attributes. Schlaggar said studies on the brain’s 
organizational principles may help scientists 
understand what happens in atypical development. 
He said most imaging studies look at the 
central tendencies of either patients and controls, 
or adults and children, and focus on the 
differences between them. 
“at’s interesting, but it doesn’t get at the 
characteristics of individual patients. What you 
want to be able to do is use the data to make 
predictions about people,” he said. “We want to 
use data pre-symptomatically. Can we identify 
information from imaging that would allow us to 
predict which child is going on to that diagnosis?”
e research is still in early stages, but 
preliminary results suggest there are some  
types of brain activity scientists may be able  
to use to make predictions, Schlaggar said.  
Over the past decade, Azad 
Bonni, MD, PhD, has contributed 
insights on how the brain is 
hardwired, and how neurons 
take shape and connect to each  
other. He also is determining 
how mutations in proteins 
implicated in autism cause 
problems. Here, Bonni (standing)  
confers with staff scientist  
Yue Yang, PhD. 
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is level of analysis requires sophisticated 
soware to crunch each person’s data. Network 
approaches are becoming increasingly useful tools 
for brain imaging research, and Schlaggar said he 
relies on Washington University’s multidisciplinary 
collaborations, such as those enabled by the IDDRC.
“It used to be that you needed supercomputers to 
do this, but not now. e computational power we 
have just by linking our desktops here is amazing,” 
he said. “It’s been a really cool experience to see 
how these methods merge, and how they provide 
the kinds of insights we didn’t anticipate we would 
have access to when we started.”
Along with MRI imaging, Constantino is using 
eye tracking to catch autism-related behavior 
abnormalities in early development. Lack of eye 
contact is a distinguishing feature of autism. 
Several years ago, Constantino’s collaborators at 
Emory University in Atlanta published research 
demonstrating that infants with autism spend less 
time focusing on people’s eyes and faces, and more 
time focusing on objects. e eye-tracking 
differences were traceable to just 2 months of age.
Constantino wanted to look deeper to 
determine whether this difference was driven by 
the kind of genetic influences that characterize 
autism. He launched a study examining identical 
and non-identical infant twins and found that the 
way babies explore the world with their eyes is 
under stringent genetic control. He and his team 
also observed that some normal infants had as low 
a level of eye- and mouth-looking as the children 
with autism in the prior study.
“ere has to be some other factor that 
combines with visual disengagement, to produce 
the autistic syndrome,” he said. “is gives us 
another opportunity to learn how susceptibilities 
to autism (like low levels of eye-looking) might be 
weathered and overcome. ese are windows of 
observation on how various components of early 
human development collide, interact with or 
compensate for one another.”
Currently, the earliest possible diagnosis for 
autism is around 1 year old. Intervention programs, 
including behavior analysis, speech and language 
instruction, and occupational therapy, typically 
don’t start until age 2. Scientists suspect that very 
early interventions might improve the chances of 
redirecting a child’s development. 
“ese three frontiers — gene discovery,  
brain imaging, and development — all feed each 
other,” Constantino said. “We need to get our 
arms around as many factors as we can. We  
are thinking about all possible places where  
disparate genetic pathways to autism converge.”
Kim Sebenoler said she hopes her family can  
help researchers find those convergences. Along 
with participating in several studies, her children 
are in behavioral therapy programs and visit 
Constantino for psychiatric appointments on a 
regular basis.
“I like the spin that Dr. Constantino puts on  
it, which is, ‘Let’s see how far you can get.’ He  
sees the potential that’s in every child — that 
there’s not limitations,” she said. “ese studies 
hopefully will end up in good results. So I’m  
very hopeful.”
NORMAL AUTISM SPECTRUM DISORDER
Eye tracking
The way young children explore the world with their eyes is 
under strict genetic control. When comparing the viewing  
habits of kids, patterns emerge. Bottom left, as illustrated  
by the crosshairs, normally developing children typically focus 
on people’s faces, particularly eyes and mouths. In atypical 
development, children fixate on inanimate objects. Identifying 
this lack of social engagement is a useful tool in early diagnosis.
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Sparking
As part of a Young Scientist 
Program field trip to the 
Medical Campus, middle 
schoolers held animal brains. 
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Youth outreach program shares the wonder 
— and career prospects — of science 
B Y  K R I S T I N  B A I R D  R A T T I N I
Curiosity
164485_YSP_CC15.indd   17 11/30/16   1:59 PM
18  Washington University School of Medicine Winter 2016-17
The decibel and excitement levels were considerably higher than usual as students huddled over preserved human hearts during biology class at Vashon High 
School in St. Louis. A visiting Teaching Team — made up of 
graduate and medical students from Washington University’s 
Young Scientist Program (YSP) — led the hands-on 
demonstration. 
Vashon biology teacher Samantha Lurie stepped back as 
the YSP team took charge, explaining how to measure blood 
pressure, use a stethoscope and identify parts of the heart.  
e team also showed the hearts of a smoker and nonsmoker, 
and discussed the related health risks. 
“e Teaching Team sparked the students’ curiosity,” she 
said. “It was great to see my students asking a lot of questions, 
and then later bragging about the experience to others.”   
Participation is the cornerstone of the YSP. For 25 years, 
the YSP has increased the participation of underrepresented 
groups in science by bringing resources directly to St. Louis-
area public schools.
Teaching Teams from the  
Young Scientist Program (YSP) 
lead hands-on demonstrations 
in area classrooms. Above, 
Vashon High School students 
build a Winogradsky column 
— a soil layer cake — during a 
presentation on ecology  
and evolution. 
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“When I first came to the School of Medicine, 
there wasn’t much going on in terms of science edu-
cation outreach to the surrounding community,” 
said James McCarter, MD, PhD, who co-founded 
the YSP in 1991 during medical school. McCarter 
now is head of research at Virta Health and an 
adjunct professor of genetics at the medical school. 
“I was struck by the differing demographics 
between the urban communities we were serving 
and the people who were doing the research on 
campus,” he said. “I wanted to open the doors of 
opportunity to a broader group of people.” 
To kick things off, an inaugural class of two 
high school students completed on-campus 
summer internships through the YSP. Now known 
as “Summer Focus,” it is a unique program that 
annually brings up to 16 outstanding high school 
students into university research labs for eight-
week intensive biomedical internships, and 
provides a stipend. To honor the YSP’s 25th 
anniversary, McCarter, his wife Rosalie Truong, 
MD, PhD, and his parents, John and Judith 
McCarter, made a $100,000 gi commitment to 
the Summer Focus Program.
e YSP since has 
expanded significantly 
beyond its flagship 
summer initiative. 
Teaching Teams 
regularly ignite the 
interests of K-12 
students in subjects 
ranging from robotics 
to forensics to 
genetics. And YSP 
Teaching Kits 
(experiments-in-a-
bag that include 
instructions and 
materials) help enable 
any adult, regardless of background, to lead 
inquiry-based science experiments with students. 
Kit topics cover nine subjects — such as DNA 
extraction and natural selection — to enhance a 
school’s science curriculum, and can be requested 
through the YSP’s website, ysp.wustl.edu. 
Additionally, the YSP hosts field trips to the 
Medical Campus and presents “Family Medical 
School,” a series of annual public workshops at the 
Saint Louis Science Center. ere, children and 
their parents learn about human anatomy and 
physiology, as well as diseases and ways to stay 
healthy. rough these and other efforts, the YSP 
has connected with more than 10,000 students.
Students leading students
roughout its growth and evolution, YSP has 
remained a volunteer-led effort. Graduate and 
medical students coordinate the program, solicit 
funding, and generously share their time and 
talents to cultivate greater diversity in the next 
generation of scientists. 
“e Young Scientist Program played a big part 
in my decision to attend Washington University,” 
said Reyka Jayasinghe, YSP co-director and a 
doctoral candidate in molecular genetics and 
genomics. “Many schools have great research and 
great faculty. But Washington University was the 
only school I could find with an opportunity for 
graduate students to mentor and work directly 
with students of all ages.”   
Volunteerism both distinguishes and enriches 
YSP tremendously. “First, the motivation of our 
leadership is entirely mission-driven, as opposed 
to a financial or professional obligation,” McCarter 
said. “Second, it allows for change. e Washington  
University students come into a leadership role for 
a year or two and move on. e program continually  
reinvents itself. Over the past 25 years, I have seen 
the program improve and iterate with each new 
generation of student leadership.” 
Boahemaa Adu-Oppong, a YSP co-director  
and doctoral candidate in evolution, ecology and 
population biology, helped launch the newest 
outreach effort: Continuing Mentoring. 
Outlook  19
In its 25 years of existence, 
the YSP has connected with 
more than 10,000 students, 
encouraging many to consider 
STEM (science, technology, 
engineering, math) careers. 
RO
BE
RT
 B
OS
TO
N
The YSP creates “experiments-in-a-bag” 
available online to K-12 schools.
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e first cohort that participated for all four  
years graduated this past May. Out of the dozen 
Soldan graduates, half are now pursuing STEM 
fields in college. 
   
Thinking in new ways
An overarching message runs through all  
of the YSP’s efforts: Consider science in the 
broadest context. “ere are a lot of ways you  
can pursue a scientific career,” said Elizabeth 
Danka, PhD, who volunteered with YSP in 
several roles during her doctoral studies in 
molecular cell biology. Danka is now a 
postdoctoral scholar at the University of  
North Carolina at Chapel Hill.
“If a student is smart, people tell them,  
‘You should be a doctor.’ Well, maybe. But not 
everyone is good at interacting with people at 
their sickest and unhappiest. 
“We help students think about the many  
ways — biomedical sciences, engineering,  
physics, and so forth — they can use their  
brain and incorporate their scientific interests  
and make an impact,” she said.
Continuing Mentoring provides a steady source 
of mentorship for science-interested students 
from Soldan International Studies High School 
and the Collegiate School of Medicine and 
Bioscience, a public magnet school. 
“ere was no curriculum when we started,” 
Adu-Oppong said. “We had to build it from scratch.” 
In the program, mentoring PhD or MD 
students meet twice monthly with the local 
students during all four years of high school and 
facilitate job shadowing opportunities with 
STEM (science, technology, engineering and 
math) professionals. Mentors also assist with 
ACT preparation, résumé making and the 
college application process. 
For Jeffrey Gamble, a doctoral candidate  
in biomedical engineering, volunteering as a 
Continuing Mentor for students at Soldan was 
an easy decision. “As a young black man from 
this area, I thought it was important for the 
students to see someone striving to do his best  
in a field that traditionally has few black people 
participating,” he said.
Gamble said some of his best mentoring 
memories are the unscripted ones, when he 
simply shared his own struggles with students.  
“I was having problems with my PhD research,” 
he explained. “I was able to show them that 
things are going to be hard, but you can push 
through it.” 
Mentor Jeffrey Gamble 
(center), a doctoral candidate 
in biomedical engineering, 
interacts with students at 
Soldan International Studies 
High School.  YSP Continuing 
Mentor volunteers meet 
regularly with students during 
all four years of high school. 
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Two years ago, Danka was paired as a Summer 
Focus mentor with India Bradley, a Cardinal 
Ritter College Prep High School student, who was 
interested in science but hadn’t chosen a specific 
focus. “I just knew I wanted to gain hands-on 
experience that summer,” Bradley said. She and 
her 15 fellow Summer Focus interns spent 40 
hours a week, for eight weeks, on the Washington 
University campus. As part of the internship, 
Bradley worked alongside Danka, researching  
E. coli strains that cause urinary tract infections. 
“Elizabeth was a wonderful role model,” 
Bradley said. “She broke everything down for  
me in a way I could understand.” Before long, 
Bradley was working independently at the lab 
bench, preparing protein gels and observing  
mice infected with E. coli strains. “It became my 
favorite part of my work, to see how the bacteria 
affected the mice and made them act,” she said. 
e program also taught Bradley to read 
scientific literature and write about her work. 
Summer Focus participants present their research 
at a concluding forum, which is proudly attended 
by family members. “It’s exciting when people 
from the community see their children succeed  
in a world-class environment,” said John Russell, 
PhD, the YSP’s faculty adviser and associate dean 
for graduate education at the School of Medicine. 
Bradley earned her first academic publishing 
credential when her Summer Focus research  
paper was accepted to the Journal for Emerging 
Investigators.  
“Now that I’m in college, I realize how much 
YSP has helped and prepared me,” said Bradley, 
who is now a sophomore majoring in biology  
and pre-medicine at Howard University on a  
full-tuition scholarship. “My professors were 
impressed that I was already published and have 
told me that this makes me more competitive for 
medical school. 
“e Summer Focus writing course put me 
ahead of my class, in terms of scientific writing. 
When I started working in the lab at Howard,  
I already knew the equipment and procedures.” 
Later, she was invited to a national conference 
to present her freshman research on bacterial 
phages. “It was a breeze,” she said, “because of  
my Summer Focus experience.” 
   
The legacy continues
Bradley is hardly alone among the 300-plus 
Summer Focus alumni in carrying YSP’s lessons 
with them into their academic and professional 
careers. In 1995, Bart Bartlett had none other  
than YSP founder Jim McCarter as his Summer 
Focus mentor. Two decades later, Bartlett, PhD,  
an associate professor of chemistry at the 
University of Michigan, still draws on his 
formative experiences. 
“Even though Summer Focus started out with 
me doing some simple lab work, Jim made certain 
I could see the connection between what I was 
doing and the goals of what the lab was doing,” 
Bartlett explained.
 “Now that I have undergraduates working in 
my lab, I try to emulate that mentorship by 
providing young people the opportunity to do 
something with their own hands in the lab, to 
contribute intellectually and to develop those 
connections,” he said. “What started at Summer 
Focus continues on.” 
Wearing prism goggles and throwing balls at a target, students 
learned about visual-motor adaptation. At first, the students 
missed the target by as much as 10 feet. As their brains adapted 
to the distorted vision, the students began hitting the mark. 
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roughout 2015, increasingly worrisome reports 
trickled out of Brazil about an obscure virus called Zika. 
A member of the flavivirus family, which includes dengue 
and West Nile, Zika was a new arrival in the Americas. 
Identified almost 70 years earlier in Africa, the virus was 
thought to cause only mild disease. In Brazil, however, it 
became associated with birth defects and a progressive 
form of paralysis known as Guillain-Barré syndrome. 
As the Zika epidemic took hold, leaders at the 
National Institutes of Health (NIH) realized they needed 
to learn about the virus quickly. ey started phoning 
select scientists, and offered funding for Zika research.
One of those researchers, Michael S. Diamond, 
MD, PhD, the Herbert S. Gasser Professor of Internal 
Medicine and Infectious Diseases, is known for his 
studies on flaviviruses. When the NIH called, the 
virologist already had been working on Zika for six 
months, collaborating with experts across the School 
of Medicine — in neurobiology, reproductive biology, 
structural biology, immunology and other fields — to 
determine what damage the virus could do and what 
could be done to stop it.
Resisting 
Zika
Undeterred, researchers tackle a
global crisis from multiple directions
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Jennifer Govero, PhD, a 
senior scientist and lab 
manager, and virologist 
Michael S. Diamond, MD, 
PhD, analyze a plaque 
assay of the Zika virus.
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L ess than a year later, the School of Medicine is one of the hotspots of Zika research. Researchers have developed 
two highly useful mouse models of Zika infection; 
identified potential drug targets to block the 
spread of the virus; showed that Zika can persist 
in the eye and testis; and identified specific 
anti-Zika antibodies that could be the basis for 
vaccines, diagnosis or treatment.
ese accomplishments are impressive, but  
not reassuring. e more researchers learn about 
the virus, the more dangerous it looks. 
“Zika hits us where it hurts. It interferes with 
our ability to have healthy babies. It damages our 
babies’ brains. It persists in people long aer the 
initial infection, so it affects our reproductive 
options in the future,” said Indira Mysorekar, 
PhD, an associate professor of obstetrics and 
gynecology, who evaluated a pregnant mouse 
model of Zika infection. “ese are all things that 
affect our humanity at a very fundamental level.”
A chance conversation
It was a chance conversation at an international 
scientific meeting devoted to another virus that  
set Diamond on a path to studying Zika. 
“e meeting was focused on chikungunya, 
but at the breaks, people get together and talk 
about all kinds of things. A colleague from Brazil 
mentioned that they were seeing unusual cases 
associated with another RNA virus, called Zika,” 
recalled Diamond. “So when I got back, members 
of my laboratory started some pilot projects.”
At the time, in June 2015, very little was  
known about Zika.
“ere was a non-human primate experiment 
done when they isolated the virus in 1947, and one 
or two other mouse experiments done in the ’70s, 
and that was about it,” Diamond said. “It seemed 
to be associated with Guillain-Barré syndrome 
and congenital defects, but causality had not  
been established.”
Over the next few months, as the Zika  
outbreak escalated thousands of miles away, 
Diamond acquired samples of the viruses,  
learned how to grow them and, along with  
Helen Lazear, PhD, now an assistant professor 
at University of North Carolina, and Jonathan 
J. Miner, MD, PhD, an instructor in medicine, 
started injecting them into mice, in the hopes of 
creating an animal model of Zika infection. 
e project hit a bump right away: Unlike 
humans, the mice were able to resist Zika infection. 
Diamond, Lazear and Miner learned that they had 
to knock out or block a part of the animals’ immune 
systems before the virus could gain a foothold. 
With this realization, they were able to create 
a mouse model of Zika infection, showing that 
the virus multiplied in the brain, spinal cord 
and testes, and developed a model of in utero 
transmission of Zika virus to fetuses.
Meanwhile, Diamond teamed up with Mysorekar 
to evaluate the sequence of events that enable Zika 
virus to be transmitted during pregnancy.
“We showed that Zika kills placental progenitor 
cells that are important for maintaining the 
health of the fetus while it’s in utero,” Mysorekar 
said, referring to a kind of cell that is capable of 
dividing and reproducing into one or more kinds 
of cells. “It also infects the fetal brain directly.  
is provides strong evidence that Zika is causing 
the brain damage we see in human newborns.”
e virus seemed to have an affinity, or 
tropism, for not just placental progenitor cells but 
other progenitor cells as well. Kevin K. Noguchi, 
PhD, an assistant professor of psychiatry, thinks 
that Zika has a tropism for neural progenitor cells, 
which may explain the neurological damage that 
occurs when fetuses are infected. 
“If you kill off a neuron, you have a net loss of 
one cell. But if you kill off a neural progenitor cell, 
you kill off every cell that it would have produced in 
the future, which can be thousands or even millions 
of neurons,” said Noguchi, who studies the effect 
of toxic exposures on the fetal brain, and recently 
began collaborating with Diamond and Miner to 
study Zika. “You can see how a virus that kills off 
neural progenitor cells could cause microcephaly.”
e kind of damage done by Zika would be  
difficult — maybe impossible — to treat.
“It’s really hard to reverse something that disrupts  
neurodevelopment because you can’t go back and  
reinitiate that development again,” Noguchi said.  
“Other parts of the brain may be able to compensate  
for some of the defects, but you can’t reverse the 
brain damage that’s already there.”
“ These are all things that affect our 
humanity at a very fundamental level.”
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of Zika in pregnant women have been reported 
in Haiti, but experts agree that the number vastly 
underestimates the problem. e Dominican 
Republic, which shares an island with Haiti and 
has better public health surveillance, has reported 
more than 1,000 cases in pregnant women.  
“e WHO-approved test for Zika is based on 
amplifying the RNA from a blood sample, and 
very few clinical labs in Haiti are set up to do 
that,” said Sarah Brown Riley, PhD, an assistant 
professor of pediatrics and of pathology and 
immunology. “It’s not that the virus isn’t there;  
it’s just that we can’t detect it.”
Brown Riley, who travels to Haiti four times a 
year, is part of a team of Haitian and American 
medical professionals, public health experts and 
scientists designing a strategy to identify possible 
cases of Zika throughout the country.
“Right now, I am trying to figure out whether 
we can diagnose Zika from dried blood spots,” 
Brown Riley said. “en we could just take a drop 
of blood, dry it onto a card, and then send it by 
motorcycle, without refrigeration, from anywhere 
in the country to one of the government labs that 
is set up to do Zika testing.”
e Haitian government is focusing on low-tech 
prevention measures, encouraging residents to 
eliminate potential breeding grounds for mosquitoes 
by draining standing water near their homes.
Local governments in the parts of the U.S. 
with Aedes aegypti mosquitoes are exhorting their 
Dodging a bullet
e Centers for Disease Control and Prevention 
estimates that lifetime costs to care for one child 
with severe microcephaly could total $10 million, 
not to mention the emotional toll on families. 
e risks in Central/South America and in the 
Caribbean are particularly high: infections in 
women who are pregnant or become pregnant 
in the near future, or in male sex partners, 
potentially could result in severe birth defects. 
Despite this very large global health problem, the 
overall risk in the U.S. is much lower. Even in 
Florida’s Miami-Dade County, the heart of the 
U.S. epidemic, fewer than 1 out of every 20,000 
people has contracted the disease locally.
“It hasn’t had much impact in the continental 
U.S. compared to developing countries, and I 
don’t expect it to,” said Steven Lawrence, MD, 
an infectious disease specialist and associate 
professor of medicine. “e most problematic 
mosquito vector — Aedes aegypti — isn’t found 
frequently anywhere in the U.S. other than along 
the Gulf Coast and in parts of the Southwest. We 
have relatively few people living without window 
screens or access to bug spray, so there just aren’t 
as many opportunities for people to come in 
contact with infected mosquitoes.”
e same cannot be said of tropical, developing 
countries such as Haiti. Only a few dozen cases 
How Zika affects fetal development
A mosquito infects the 
mother, transmitting 
the virus to her 
bloodstream.
Zika breaches fetal circulation, causing potential 
placental insufficiency and damaging neurons.
Potential adverse 
outcomes
• Microcephaly
•  Intrauterine growth 
restriction
• Ocular abnormalities
• Fetal death
Other long-term effects  
are unknown.
Microcephaly
Typical head size
If a pregnant woman is infected with Zika, the fetus may develop 
abnormalities, including one of the most striking results — microcephaly. 
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The testicles of male mice 
showed cellular damage and 
shrinkage three weeks after 
Zika infection. On the left is  
a healthy mouse testicle; on  
the right, a testicle following 
Zika infection.
Zika reduces fertility in male mice
Studies needed to determine whether men are similarly affected
Most Zika research focuses on how the virus affects 
pregnant women and causes 
severe birth defects.
A study in mice indicates that 
the virus also targets the male 
reproductive system, suggesting  
that Zika may have consequences  
for men. The study was published  
last October in Nature.
“While our study was in mice 
– and with the caveat that we 
don’t yet know whether Zika has 
the same effect in men – it does 
suggest that men might face low 
testosterone levels and low sperm 
counts after Zika infection, affecting 
their fertility,” said Michael Diamond, 
MD, PhD, a co-senior author on the 
study and the Herbert S. Gasser 
Professor of Medicine.
To find out how the Zika 
virus affects males, Diamond, 
co-senior author Kelle H. Moley, 
MD, the James P. Crane Professor 
of Obstetrics and Gynecology, and 
colleagues injected male mice with 
the Zika virus. 
After one week, the virus 
had migrated to the testes, 
which bore microscopic signs of 
inflammation. In three weeks, 
their testicles had shrunk to one-
tenth of their normal size and the 
internal structure was completely 
destroyed. Sex hormone levels had 
dropped and fertility was reduced. 
These mice were less likely to 
impregnate female mice.
The mice were monitored until 
six weeks, and in that time their 
testicles did not heal, even after  
the mice had cleared the virus 
from their bloodstreams.
“We don’t know for certain if 
the damage is irreversible, but I 
expect so, because the cells that 
hold the internal structure in place 
have been infected and destroyed,” 
Diamond said. 
“This is the only virus I know 
of that causes such severe 
symptoms of infertility,” said Moley, 
a fertility specialist and director 
of the university’s Center for 
Reproductive Health Sciences. 
Diamond and Moley said 
human studies in areas with high 
rates of Zika infection are needed 
to determine the impact of the 
virus on men’s reproductive health.
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Kelle H. Moley, MD, Andrea Drury, research 
technician, and Prabagaran Esakky, PhD, the 
study’s first author and instructor in obstetrics and 
gynecology, meet to discuss the latest Zika findings.
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residents to do the same, and in addition, some 
also are spraying insecticides. But the best hope 
for a permanent solution is a vaccine.
Daved H. Fremont, PhD, a professor of 
pathology and immunology, has been working on 
developing a Zika vaccine. A vaccine made from a 
live but weakened virus would be relatively simple 
to create, but it could not be used in pregnant 
women because the virus, although weakened, 
could still be strong enough to infect the fetus and 
cause disease.  
Earlier this year, Fremont identified a portion 
of a Zika protein that elicits a strong, protective 
antibody response. He plans to collaborate with a 
primate research facility in Oregon to test whether 
the engineered vaccines protect non-human 
primates against Zika infection. 
Diamond, in collaboration with Fremont, 
Mysorekar and researchers at Vanderbilt University, 
recently has shown that human antibodies can 
protect developing fetuses from Zika infection 
and adults from Zika disease, at least in mice. e 
discovery suggests that treating pregnant women 
with anti-Zika antibodies may prevent the worst 
outcomes — microcephaly and other birth defects 
— and that a vaccine eliciting similar antibodies 
could do the same.
Where next?
Despite the enormous progress made by the ever-
growing community of Zika researchers, there is 
much work le to be done, including:
•    Determining whether Zika can cause brain 
damage in children and adults. Neural 
progenitor cells, which are abundant in fetuses, 
are still present, although at much lower 
numbers, aer birth. Robyn S. Klein, MD, 
PhD, a professor of infectious diseases and 
neuroscience, studies the impact of the virus 
on neurodevelopment, with an emphasis on 
learning and memory.
•    Identifying other routes of transmission. 
Haina Shin, PhD, an assistant professor of 
medicine, is studying protective immunity 
against sexually transmitted Zika, as well 
as risk factors that may make women more 
susceptible to this form of transmission. 
Mysorekar, an associate director of the 
Center for Reproductive Health Sciences, is 
researching how the virus crosses the placental 
barrier, which separates maternal and fetal 
bodily fluids. Rajendra S. Apte, MD, PhD, 
the Paul A. Cibis Distinguished Professor of 
Ophthalmology and Visual Science, co-led 
a team (with Diamond and Miner) that 
characterized Zika in the eye and demonstrated 
presence of virus in tears. He is now studying 
whether corneal transplants could transmit the 
virus. is is the most common transplantation 
surgery in the U.S., with about 40,000 
performed yearly. 
•    Determining the effect of Zika virus on 
fertility. See story, previous page.
e list of unanswered questions is daunting,  
but Diamond is undeterred. e lesson of Zika is 
not that epidemics can spring up out of nowhere, 
although that is true, he said. e true lesson is that 
the scientific community has shown itself to be up  
to the task of responding to such epidemics. 
“While it was true that few were studying Zika 
before last year, it’s not true that we weren’t prepared 
for this outbreak. Within a very short period of time 
we’ve generated vaccine candidates, therapeutic 
candidates, and animal models both in mice and 
non-human primates,” Diamond said. “It shows that 
by studying basic properties of pathogens, whether it 
is bacteria, viruses, or otherwise, we’ll learn enough 
so that if something does happen, we’ll be prepared, 
poised and nimble enough to move into the field 
very quickly to make significant progress. And that’s 
what’s been done in Zika.”
Zika battlefronts
Diagnosis and surveillance
Maternal-fetal transmission
Other routes of transmission
Animal models
Reproductive medicine
Fetal brain development
Neurological effects on adults
Ocular health
Vaccine, drug development
School of Medicine researchers have 
mounted a cross-disciplinary response:
The Zika virus
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School of Medicine investigators 
are harnessing  
new technologies to create precision and personalized 
approaches to diseases — advances that could not 
occur without prior investments in basic research.
“Basic research is a key driver of biomedical discovery  
and an essential part of the robust research environment at  
the School of Medicine,” said David H. Perlmutter, MD,  
executive vice chancellor for medical affairs and dean of the 
School of Medicine. 
“Our university boasts a uniquely collaborative culture in 
which basic, clinical and translational scientists work together 
to explore some of the world’s most challenging medical  
problems,” he said.
Investments in basic 
science fundamental 
to biomedical 
discovery
New endowed professors 
in basic science, from left, 
Linda J. Pike, PhD, Phyllis 
I. Hanson, MD, PhD, and 
Tamara L. Doering, MD, PhD. 
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In keeping with the medical school’s commitment  
to basic research, three outstanding women scientists  
recently were awarded endowed professorships. 
e funding will enable them to initiate promising 
research projects, while teaching the next generation  
of scientists and medical professionals. “Endowed 
professorships reward and honor those who do 
extraordinary work,” Perlmutter said.
e new endowed professors are:
Linda J. Pike, PhD, the Alumni Endowed 
Professor of Biochemistry and Molecular Biophysics
Phyllis I. Hanson, MD, PhD, the Gerty T. Cori 
Professor in the Department of Cell Biology and 
Physiology 
Tamara L. Doering, MD, PhD, the Alumni 
Endowed Professor of Molecular Microbiology 
e three awardees share a common passion  
for solving complex biological puzzles and are 
strong advocates for basic research.
“Essentially all of the progress made in the  
past 50 years in identifying new drugs has been  
a result of basic science research,” Pike said. 
“In my own field of cancer research, in the  
last 30 years I have seen medicine go from having 
absolutely no understanding of what drives cancer 
to now having dozens of drugs that specifically 
target the many different proteins that drive  
cancers,” she added. “None of this would have 
been possible without the work of basic scientists.”
 
Improving cancer outcomes
Pike is studying how cell-surface receptors in the 
tyrosine kinase family stimulate cell proliferation, 
a process that can result in breast, lung and other 
types of cancers. Tyrosine kinase-inhibiting drugs,  
which resulted from this type of work, are used 
by oncologists worldwide, and dramatically have 
improved outcomes for cancer patients. e 
insights provided by Pike’s work also may lead  
to additional targeted therapies.  
Hanson agrees. “Most, if not all, diseases and  
disorders originate in problems or defects at the  
cellular and molecular level,” she said. “Understanding 
how cells and the molecules within them normally 
work is critical to understanding how diseases arise 
and how to treat these diseases.” 
Like Pike, Hanson focuses on cellular function, 
investigating how other proteins interact to 
regulate the structure and organization of cell 
membranes both inside and outside the cell. 
Her work has clinical applications in cancer, 
neurodegenerative disease, including Alzheimer’s 
disease, and the debilitating movement disorder 
dystonia. Hanson is a member of the Hope Center 
for Neurological Disorders, and collaborates with 
scientists in neurology and ophthalmology. 
Halting deadly infections
While Doering shares her colleagues’ fascination 
with the microscopic, her work focuses on one 
significant pathogen. She has devoted almost 
20 years to studying the pathogenic yeast 
Cryptococcus neoformans. is microbe causes 
fungal meningitis, which has a devastating effect on 
immunocompromised individuals worldwide, and 
also causes disease in immunocompetent people. 
Doering is investigating a feature unique to the 
organism: its polysaccharide capsule, which plays a 
key role in the infection process. She has conducted 
biochemical and genetic studies to identify the 
cellular machinery involved in producing the 
capsule. Her work could lead to new medications 
to combat the deadly fungus, which are greatly 
needed, especially in resource-limited settings.
Women in leadership
e women acknowledge that it is a great honor to 
be named endowed professors.
Hanson said she is thrilled and humbled to hold 
the professorship honoring the late Gerty T. Cori, a 
Washington University faculty member who, with 
husband and fellow faculty Carl Cori, also deceased, 
won the 1947 Nobel Prize for Physiology or Medicine 
for their work on cellular metabolism. “Gerty Cori 
exemplifies how a single-minded commitment 
to understanding a specific mechanism or set of 
mechanisms can have an extremely broad impact,” 
she said. “Carl and Gerty Cori’s accomplishments led 
to many applications downstream.”
e presence of women in leadership positions 
sends a strong message to talented young women 
considering science careers, said Pike and Doering.
“It is really important for young women to see 
that women who do good science are rewarded 
in the same way that men are,” said Pike, who 
co-founded the Academic Women’s Network 
(AWN) at the School of Medicine.
“Such awards are important not only for career 
development of the scientist, but also for raising 
the visibility of women researchers, which, in turn, 
helps provide role models for women trainees,” 
Doering added.
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The three researchers 
focus on: (top to bottom) 
protein receptors, cell 
membrane pathways  
and pathogenic fungi.
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Deep appreciation for medical school spurs alumni support across decades 
Robert Parsons, MD ’54, began his career as a  plastic surgeon over a half century ago. He is  one of the medical school’s longest continuous 
donors and has given annually for 61 years.  
Emily Beck, MD ’13, a fourth-year dermatology resident,  
is the new chair of the Annual Fund, which is supported  
by unrestricted gis from alumni and former house staff.  
is fund benefits scholarships, educational initiatives  
and community outreach, among other activities.
Both view philanthropy as a way to ensure that 
Washington University remains at the forefront of  
medical education and research for years to come. 
Beck and Parsons recently spoke about their dedication 
to Washington University, and how all gis, large and 
small, make a difference.
B Y  H I L A R Y  D A V I D S O NGenerations
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Why did you decide to  
support Washington 
University so soon after 
medical school?
Parsons       
I’ve always felt it was my 
responsibility to give back to the 
school that provided my training. 
Even though we couldn’t give a  
lot of money in 1957, my wife and 
I wanted to support the school that 
prepared me for my career. I was  
very lucky to get accepted into 
Washington University.   
Beck      
I feel strongly tied to the School  
of Medicine and am grateful for  
the opportunities I received, which  
motivated me to find ways to get 
involved and help support the school.
I was interested in chairing the 
Annual Fund because it provides  
so many opportunities to students,  
faculty and house staff. As a student,  
I realized that supporting it is one 
way to help our school remain one  
of the best medical schools in the 
country and help it continue to grow.
 
Have you directly experienced 
how philanthropy helps 
students?
Parsons      
Alumni support makes an enormous  
difference in students’ ability to finance 
their educations. I’ve been working 
with medical students for years, and 
the debt load is overwhelming for 
them. I was fortunate that it didn’t 
cost as much when I went to medical 
school. 
at’s why, in addition to giving 
every year, I created the Robert W.  
and Elise Hampton Parsons Scholarship.  
Annual Fund gifts support wide-ranging 
educational and service initiatives, 
including scholarships; simulation 
centers; the Saturday Neighborhood 
Health Clinic, providing health care 
to the uninsured; the Young Scientist 
Program, teaching hands-on science 
investigation to area youth; the 
Forum for International Health and 
Tropical Medicine (FIHTM), offering 
study abroad opportunities; and the 
Geriatrics Outreach Group, hosting 
intergenerational events and dialogue.
Scholarships: 68%
Student groups, educational  
initiatives and community  
outreach: 24%
Other student activities: 6%
Academic and honor societies: 2%
68%
24%
6%
2%
Annual
Fund
allocation
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In 2013, Congress voted that you 
could make a one-time gi out of your 
IRA without tax consequences. I had 
made arrangements in my will for the 
scholarship, but I thought it could help 
more students if I did it now. at law 
has since become permanent.
I’m so glad I did. I met a couple  
of the scholarship students at the 
Scholarship Dinner last year. I was 
very impressed. I don’t know if I could 
get into medical school nowadays! 
Beck
Many of my friends received  
scholarships like the one Dr. Parsons 
created, and said that scholarship 
support made the difference between 
coming to Washington University 
and going somewhere else. rough 
Annual Fund support, others went 
on international trips where they 
learned about medicine in different 
environments, and lots of us received 
our first clinical experiences at the 
Saturday Neighborhood Health Clinic.
I don’t think people realize  
how necessary philanthropy is to 
maintaining the caliber of this school. 
For one thing, it supports the amazing 
faculty here in teaching and research.
Tuition alone doesn’t cover the cost 
of training the next generation of  
physicians and scientists. It’s up to  
us to do that.
What would you say to 
alumni who cannot afford to 
make large contributions?
Parsons      
Every contribution counts, whether 
it’s a little bit or a lot. Many of us 
feel an obligation to those who have 
educated us, and alumni gis support 
an outstanding medical education for 
students, residents and fellows. 
Beck     
As Annual Fund chair, one of my goals 
is to communicate how important it is 
to give. Young alumni especially need 
to know that small donations make a 
huge difference.
For example, last year the number 
of donations that were less than $100 
actually added up to $1.8 million. So, 
smaller donations really add up to 
make a huge contribution.
Even young professionals not yet 
well-established in their careers can 
make a big impact with their gis. 
Stable support of small amounts over 
time, like those from Dr. Parsons, not 
only demonstrates a commitment to 
the school, it provides meaningful 
resources to current students. 
Loyalty Society
JOIN US TODAY!
      
The Washington University Loyalty 
Society was created to celebrate 
those who, like Parsons and Beck, 
have committed to Washington 
University School of Medicine and 
its mission of teaching, patient care 
and research. The society is open 
to students, alumni, residents and 
fellows who give consecutively for 
at least two fiscal years. Donors are 
automatically inducted and remain 
members each year a contribution is 
made. Membership benefits include 
gifts of appreciation, recognition 
in the annual Honor Roll of Donors, 
and invitations to special events. 
For more information,  
contact Medical Alumni and 
Development at 314-935-9691 
or meddev@wustl.edu.
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classnotes
1950 S
William “Bill” A. Reynolds, MD 56, 
was awarded the Centennial Legacy 
Award from the Montana chapter of the 
American College of Physicians in 2015, 
and continues to serve on the Board of 
Directors for Intermountain Children’s 
Home in Helena, Mont.
Akie Ruth Oshiro, NU 57, is still 
employed at age 81 by the Los Angeles 
Unified School District, checking middle 
school students’ vision. She enjoys work-
ing with the students and other retired 
nurses. She is delighted to report that her 
granddaughter plans to go into nursing.
Shirley Martin, GN 58, reports that, after 
a long and successful career as a dean at 
several institutions, including Florida State 
University, Indiana State University and 
the University of Missouri-St. Louis, she is 
enjoying retirement.
1960 S 
Mordecai P. Blaustein, MD 61, served 
as an associate editor of the American 
Journal of Physiology — Heart and 
Circulatory Physiology and was elected 
as a fellow of the American Physiological 
Society in 2015.
Elissa Brown, NU 69, is a psychiatric/
mental health clinical nurse specialist, and 
retired from the VA Greater Los Angeles 
Healthcare System two years ago. She is 
still very involved in nursing activities, 
serving on boards and committees for the 
American Nurses Association (ANA), the 
ANA-California, the National Association 
of Clinical Nurse Specialists, the California 
Association of Clinical Nurse Specialists, 
and the Ethics of Caring collaboration.
1970 S 
Ted Harrison, MD 75, has opened  
a practice in the new specialty of  
regenerative medicine in Port Angeles, 
Wash. His book, “Regenerative Medicine,” 
was published in spring 2015.
1980 S 
Irwin Feuerstein, MD 82, began a new 
position as medical officer with the Office 
of Research on Women’s Health at the 
National Institutes of Health (NIH) in 
Bethesda, Md.
Find your friends.
Classnotes are organized first by year of degree/training  
completion and then in alphabetical order. 
How about you?
Share your news via the online form at wumcnews.org/classnotes. 
Submissions will be printed in a subsequent issue of Outlook  
magazine as space allows. Photos are welcome.
Frontlines 
When ophthalmologist Lowell Gess, MD ’51, flew to Freetown, Sierra 
Leone, in January 2015, he knew he was 
entering a “lion’s den.” Just five months 
earlier, an Ebola epidemic had broken out, 
causing the World Health Organization to 
declare a state of emergency in West Africa. 
Conditioned to risk by his 50-plus years 
as a medical missionary, Gess brought 
$60,000 worth of donated medical supplies 
and monetary donations from his church. 
His latest book, “Ebola’s Den,” recounts his 
experiences. Gess has been volunteering in 
Africa for decades and in the 1980s helped 
found the Kissy UMC Eye Hospital in 
Freetown. “Ebola’s Den” is his fourth book.
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Richard W. Gross, HS 82, received the 
Solomon A. Berson Medical Alumni 
Achievement Award in Basic Science from 
the New York University (NYU) School of 
Medicine in April 2016. It is awarded to  
a NYU School of Medicine graduate who 
has distinguished himself or herself by 
major accomplishments in fundamental 
scientific research.
Walter Peters, MD 82, was named chief of 
the Division of Colon and Rectal Surgery at 
Baylor University Medical Center in Dallas.
Alison Whelan, MD 86, was named the 
new chief medical education officer of the 
American Association of Medical Colleges 
(AAMC) following a nationwide search.  
She will lead initiatives to transform the 
current models of education and workforce 
preparation across the full continuum of 
medical education. She also will lead AAMC 
efforts that support medical education  
officers, regional campuses, education 
researchers, students and residents. Whelan 
served previously as associate dean for 
medical student education at WUSM.
1990 S 
Jeffrey Dale Grills, MD 90, was named 
vice president of medical affairs for 
Freeman Health System in Joplin, Mo.
Stephanie Bullard Lancaster, OT 91, is 
an assistant professor in the Department 
of Occupational Therapy at the University 
of Tennessee Health Science Center in 
Memphis. Lancaster lives with her husband 
and two daughters in Collierville, Tenn.
Marc Bernstein, MD 92, is serving as 
the 2016-2017 president of the Executive 
Council of the Washington University 
Medical Center Alumni Association.
2000 S
Yi Wang, MD 13, recently completed a year 
abroad in Lesotho (Southern Africa) work-
ing at the Center of Excellence for HIV care 
and Queen Mamohato Memorial Hospital.
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Teaming up 
Alumni Lee M. Krug, MD ’94, left, and Chris Boerner, LA ’93, made a stop at 
Brookings Hall in September before continuing their cross-country ride to 
raise money for cancer research. The ride extended from the Oregon Coast 
to New Jersey. All participants in the annual Coast 2 Coast 4 Cancer Ride 
are cancer researchers with Bristol-Myers Squibb. Krug is Immuno-oncology 
Disease Head for Thoracic and GI Malignancies, and Boerner is president and 
head of U.S. commercial business. Both are based in New Jersey.
From left, Jennifer Gould, MD ’97, HS ’98, HS ’02, John Stoffel, MD 
’97, and Rekha Rao, MD ’97, got a 
great surprise when they ran into 
one another on a Mediterranean 
cruise. The three members of the 
Class of ’97 planned vacations  
separately and found each other  
on the second day of their cruise. 
They are set to celebrate again, this 
time with all of their classmates, at 
their 20th Medical School Reunion 
April 27-30, 2017.
Small world 
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In Memoriam
1940S 
Rita J. Hustava, NU 47; April ’16
Lindsay J. Kirkham Jr., MD 46; Aug. ’16
Charles R. Park, GM, HS 49; May ’16
Arthur Schmidt Jr., MD 46; Aug. ’16
Gerry A. Smyth, MD 47; May ’16
S. Ernest Torigoe, DE 44; Feb. ’16
Glenn Turner, MD 42; Aug. ’16
 1950S
Richard H. Fallon, HS 57, GR 74; June ’16
Ashby Grantham, LA 52, MD 55; Sept. ’16
Adolphe Kiczales, HS; Aug. ’16
James Nelson, HS; Sept. ’16
Richard Royer, HS 51; Aug. ’16
Robert Rubin, LA 50, MD 54; Jan. ’16
Roger Schuessler, MD 55; July ’16
Anwar A. Shah, HS 57; April ’16
Marcia L. Shouse, NU 54; Jan. ’16
Ljubinka “Lili” Vojcanin, NU 50; March ’14
Patricia Waterfield, PT 56; Sept. ’16
Joseph R. Williamson, MD 58; June ’16
 1960S
Alan L. Brodsky, MD 67; Sept. ’16
Robin Lowy, NU 69, LA 69; May ’16
David Sirota, MD 60; April ’16
John C. Soucy Jr., HS 63; May ’16
Jerrold Vesper, DE 65; Aug. ’16
Newton B. White, HS 66; April ’16
 1970S
Thomas Black Jr., GB 75, DE 75; Aug. ’16
Wendy Eider, MD 76; March ’16
Christopher Maret, MD 79; June ’16
Julian Mosley, MD 72; Sept. ’16
Susan Nelson, MD 78; May ’16
M.S. Rao, HS 71; May ’16
Joseph Swope, HS; June ’16
 1980S
Kevin Kowaleski, MD 80; Sept. ’16
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Pioneer Jessie Ternberg dies at 92
The first female surgical resident at Barnes Hospital, Ternberg served for decades at the  
School of Medicine and St. Louis Children’s Hospital
In 1954, when Jessie L. Ternberg, PhD, MD, became the first female surgical resident at Barnes Hospital in St. Louis, her male peers did not extend a warm welcome. Ternberg forged 
on, paving the way for women in medicine, and serving on the 
School of Medicine faculty for 37 years.
A professor emerita of surgery and of surgery in pediatrics, 
Ternberg died July 9, 2016, of natural causes while vacationing in 
Zermatt, Switzerland, one of her favorite places, according to 
longtime friend Mabel Purkerson, MD, also a School of Medicine 
professor emerita. Ternberg, of Creve Coeur, Missouri, was 92.
Ternberg earned a bachelor’s degree from Grinnell College in 1946 and a  
doctorate in biochemistry from the University of Texas at Austin in 1950. There,  
she and Robert Eakin, PhD, reported their discovery of the mechanism by which 
Vitamin B-12 is absorbed in the intestine, helping to establish a cure for pernicious 
anemia. In 1953, she graduated from Washington University School of Medicine.
During an internship at Boston City Hospital, Ternberg decided she wanted to be  
a surgeon. When she couldn’t find a surgical residency program that would consider 
a female applicant, she wrote to Carl Moyer, MD, the head of surgery at Washington 
University. “I told him I thought it was a bum rap they wouldn’t take women,” 
Ternberg once said. “He agreed — and he accepted me.”
There were still many obstacles to overcome. “She had to be twice as good and 
twice as smart as everybody else to survive, and she was,” said longtime friend 
Timothy J. Eberlein, MD, the Bixby Professor of Surgery and head of the Department 
of Surgery and director of Siteman Cancer Center. “She 
had a fierce determination, and that’s probably how 
she overcame all those obstacles over the years. She 
was like that to the end.”
In 1959, she became an instructor in surgery.
Promoted to professor in 1971, she helped establish 
the Division of Pediatric Surgery and was named its 
director in 1972. She became the first woman to be 
elected head of the medical school’s faculty council.
Ternberg routinely performed more than 500  
operations a year, and led a surgical team in  
successfully separating two sets of conjoined twins,  
connected at the pelvis, a very rare condition. 
In 1993, former pediatric surgical residents and  
colleagues established the Jessie L. Ternberg Award,  
to be given annually to a female medical graduate 
exemplifying Ternberg’s “indomitable spirit of determi-
nation, perseverance and dedication to her patients.”
In 2000, Ternberg was named a fellow of the 
American Association for the Advancement of Science. Her book, “A Handbook for 
Pediatric Surgery,” became known as the bible of pediatric surgery and made her 
name familiar to a generation of pediatric surgeons.
In 2009, friends and admirers funded the Jessie L. Ternberg, MD, PhD, 
Distinguished Professorship in Pediatric Surgery. Ternberg is survived by a  
multitude of friends, and by her nieces and nephews.
Jessie L. Ternberg, 
PhD, MD
Ternberg (right) in surgery.
For full obituaries, visit: 
wumcnews.org/obits
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Advancing Health, 
          Transforming Lives
Great news! The law allowing tax-free charitable IRA gifts is now permanent.  
If you are age 70½ or older, you can reduce your taxable income by making tax-free 
gifts up to $100,000 each calendar year directly from your IRA to Washington  
University School of Medicine. Best of all, your gift will be used as you wish to  
support scholarships, professorships, research or another purpose you choose! 
Make a tax-free charitable  
IRA gift and:
n  Reduce your taxable income
n  Satisfy your required minimum distribution
n  Support the School of Medicine
 
 
To learn more or notify us of your gift,  
contact Medical Alumni and Development  
at 314-935-9691 or meddev@wustl.edu. 
For help in planning a gift in your estate,  
contact Planned Giving at 800-835-3503  
or plannedgiving@wustl.edu.
To qualify:
n   You must be 70½ years of age or older when  
the distribution is made.
n   The transfer must go directly from your IRA to 
Washington University.
n   Your gift must be outright. Tax-free charitable IRA 
gifts cannot be used to fund a gift annuity, charitable  
trust, donor-advised fund or private foundation.
Consult with your legal or tax adviser before making a charitable gift.
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The two Nobel Prize medals awarded to Carl and Gerty Cori in 1947 for their work on sugar metabolism are on permanent display at the Center for the History of Medicine in Becker Medical Library. Their son, Thomas Cori, PhD, donated the  
medals to the School of Medicine. Carl Cori and Gerty Radnitz met in 1914 as first-year 
medical students at the University of Prague, married in 1920, and immigrated to the  
U.S. In 1931, Washington University offered Carl and Gerty positions, but the offers 
weren’t equal. Carl was named head of the Department of Pharmacology, and Gerty 
became a research associate, reportedly at one-tenth of Carl’s salary. Fifteen years later, 
Gerty finally was promoted to professor. She became the first American woman to 
win the Nobel Prize in physiology or medicine. Remarkably, six 
people who trained in the Cori lab went on 
to win Nobel Prizes. 
Prized collection  
 Cori medals on permanent display
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See video at 
outlook.wustl.edu
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Living hip replacements
Orthopedics researchers and biotech firm Cytex 
Therapeutics are developing alternatives to joint-
replacement surgery. Using a weaving pattern to mimic 
the structure and properties of cartilage, biodegradable 
fibers are bundled to create a high-performance fabric 
scaffold to fit exactly over a hip joint. The fibers are 
coated with cartilage prior to implantation. Over time, 
the scaffolding dissolves, leaving only the new tissue 
behind. See story, page 2.
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